Abstract
After ischemic stroke, partial recovery of function frequently occurs and may depend on the plasticity of axonal connections. Here, we examine whether blockade of the Nogo-NogoReceptor (NgR) pathway might enhance axonal sprouting and thereby recovery after focal brain infarction. Mutant mice lacking NgR or Nogo-AB recover complex motor function after stroke more completely than do control animals. After a stroke, greater numbers of axons emanating from the undamaged cortex cross the midline to innervate the contralateral red nucleus and the ipsilateral cervical spinal cord; this axonal plasticity is enhanced in ngr -/- or nogo-ab -/- mice. In rats with middle cerebral artery occlusion, both the recovery of motor skills and corticofugal axonal plasticity are promoted by intracerebroventricular administration of a function-blocking NgR fragment. Behavioral improvement occurs when therapy is initiated 1 week after arterial occlusion. Thus, delayed pharmacological blockade of the NgR promotes subacute stroke recovery by facilitating axonal plasticity.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Animals
-
Axons / drug effects
-
Axons / metabolism*
-
Behavior, Animal / drug effects
-
Behavior, Animal / physiology
-
Disease Models, Animal
-
GPI-Linked Proteins
-
Infarction, Middle Cerebral Artery / genetics
-
Infarction, Middle Cerebral Artery / metabolism
-
Infarction, Middle Cerebral Artery / therapy
-
Male
-
Mice
-
Mice, Knockout
-
Myelin Proteins / genetics*
-
Myelin Proteins / metabolism
-
Neuronal Plasticity / drug effects
-
Neuronal Plasticity / genetics
-
Neuronal Plasticity / physiology*
-
Nogo Proteins
-
Nogo Receptor 1
-
Rats
-
Rats, Sprague-Dawley
-
Receptors, Cell Surface / genetics*
-
Receptors, Cell Surface / metabolism
-
Receptors, Peptide / antagonists & inhibitors*
-
Recombinant Fusion Proteins / genetics
-
Recombinant Fusion Proteins / pharmacology*
-
Recovery of Function / drug effects
-
Recovery of Function / genetics*
-
Stroke / genetics
-
Stroke / metabolism
-
Stroke / therapy*
-
Treatment Outcome
Substances
-
GPI-Linked Proteins
-
Myelin Proteins
-
NgR(310) Ecto-Fc protein
-
Nogo Proteins
-
Nogo Receptor 1
-
Receptors, Cell Surface
-
Receptors, Peptide
-
Recombinant Fusion Proteins
-
Rtn4 protein, mouse
-
Rtn4 protein, rat
-
Rtn4r protein, mouse
-
Rtn4r protein, rat